由 CAR-T 细胞来源外泌体与脂质体组成的序贯靶向杂合纳米囊泡用于增强肿瘤免疫化疗

Sequential Targeting Hybrid Nanovesicles Composed of Chimeric Antigen Receptor T-Cell-Derived Exosomes and Liposomes for Enhanced Cancer Immunochemoth

由于脂质体的肺靶向能力，静脉给药的 Lip-CExo@PTX 有超过 95% 蓄积于肺组织。